Patent Applications published on Oct 3, 2024 - page 4

#901
US20240325380A1
Human necessities

COMPOSITIONS FOR OPIATE AND OPIOID PREVENTION AND REVERSAL, AND METHODS OF THEIR USE

#902
US20240325381A1
Human necessities

USE OF FLUNARIZINE AND METHOD FOR CONTROLLING NUMBER OF INTERCELLULAR MITOCHONDRIA

#903
US20240325382A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING ANEMIA ASSOCIATED WITH A RIBOSOMAL DISORDER

#904
US20240325383A1
Human necessities

Small Molecule Targeting of BRD4 for Treatment of COVID-19

#905
US20240325384A1
Human necessities

DOSING REGIMEN

#906
US20240325385A1
Human necessities

ANTI-TUMOR PHARMACEUTICAL COMPOSITION COMPRISING EZH2 INHIBITOR AND SCD1 INHIBITOR AND USE THEREOF

#907
US20240325386A1
Human necessities

THERAPEUTIC AGENT FOR COVID-19

#908
US20240325387A1
Human necessities

COMBINATION THERAPY

#909
US20240325388A1
Human necessities

DOSAGE FORMS FOR TYK2 INHIBITORS COMPRISING SWELLABLE CORES

#910
US20240325389A1
Human necessities

NEW THERAPEUTIC TARGETS WITH AN ANTI-INFLAMMATORY AND ANTI-INTERFERON EFFECT

#911
US20240325390A1
Human necessities

IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF

#912
US20240325391A1
Human necessities

DOSAGE REGIMENS FOR PARP7 INHIBITORS

#913
US20240325392A1
Human necessities

CYTOTOXICITY TARGETING CHIMERAS FOR CCR2-EXPRESSING CELLS

#914
US20240325393A1
Human necessities

TOFACITINIB-CONTAINING ANHYDROUS ELASTOMER-BASED GEL FORMULATIONS

#915
US20240325394A1
Human necessities

SALT AND CRYSTAL FORM OF NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

#916
US20240325395A1
Human necessities

REAGENT AND METHOD FOR TREATING SKIN DISEASES OR CONDITIONS ASSOCIATED WITH ANTI-TUMOR AGENT

#917
US20240325396A1
Human necessities

METHODS FOR TREATING CANCER

#918
US20240325397A1
Human necessities

USE OF COMBINATION THERAPY FOR TREATING CANCER

#919
US20240325398A1
Human necessities

COMBINATION THERAPIES

#920
US20240325399A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CHOLANGITIS OR LIVER DISEASE CAUSED BY CHOLANGITIS COMPRISING ADENOSINE DERIVATIVE

#921
US20240325400A1
Human necessities

Composition Comprising Skin-Specific T Cell Inhibitor as Active Ingredient for Prevention or Treatment of Atopic Dermatitis

#922
US20240325401A1
Human necessities

METHODS OF TREATING BRAIN TUMORS USING COMBINATION THERAPY

#923
US20240325402A1
Human necessities

MOMELOTINIB COMBINATION THERAPY

#924
US20240325403A1
Human necessities

TREATMENT OF CANCER WITH A RAF INHIBITOR

#925
US20240325404A1
Human necessities

TREATMENT OF INFLAMMATORY DISEASES

#926
US20240325405A1
Human necessities

COMPOUND USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES

#927
US20240325406A1
Human necessities

ANTIBACTERIAL COMPOSITIONS

#928
US20240325407A1
Human necessities

METHODS AND COMPOSITIONS FOR POTENTIATING THE ACTION OF OPIOID ANALGESICS USING IBOGA ALKALOIDS

#929 ✅ Patent 12,220,418 granted on 2025-02-11
US20240325408A1
Human necessities

Olanzapine compositions and methods of use

#930
US20240325409A1
Human necessities

Fused Heterotetracyclic Antiviral Agents

#931
US20240325410A1
Human necessities

COMPOSITION, FORMULATIONS AND METHODS OF MAKING AND USING BOTANICALS AND NATURAL COMPOUNDS FOR THE PROMOTION OF HEALTHY BRAIN AGING

#932
US20240325411A1
Human necessities

CONCENTRATED LIQUID PHARMACEUTICAL FORMULATIONS OF FUROSEMIDE AND METHODS OF ADMINISTERING THE SAME

#933
US20240325412A1
Human necessities

COMBINATIONS

#934
US20240325413A1
Human necessities

FORMULATIONS FOR THE TREATMENT OF RESPIRATORY DISORDERS

#935
US20240325414A1
Human necessities

CONSTITUENT, DERIVATIVE OR EXTRACT OF CANNABIS IN A WATER SOLUBLE MATRIX

#936
US20240325415A1
Human necessities

COMPOSITIONS COMPRISING A CONSTITUENT, DERIVATIVE OR EXTRACT OF CANNABIS

#937
US20240325416A1
Human necessities

ORAL SOLID DOSAGE FORMS COMPRISING CANNABINOIDS

#938
US20240325417A1
Human necessities

COMBINATION THERAPY FOR TREATMENT OF LIVER DISEASES

#939
US20240325418A1
Human necessities

BORATE COMPLEXES OF CHLOROGENIC ACID AND USES THEREOF

#940
US20240325419A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR RESTORING PHYSIOLOGICAL PROCESSES AND CELLS OF ORGANISM

#941
US20240325420A1
Human necessities

COMPOSITION INCLUDING PAEONIFLORIN FOR PREVENTION OR TREATMENT OF CACHEXIA AND MUSCLE LOSS

#942
US20240325421A1
Human necessities

PTEN INHIBITORS FOR TREATMENT AND PREVENTION OF BONE MARROW LOSS

#943
US20240325422A1
Human necessities

MARIBAVIR ISOMERS, COMPOSITIONS, METHODS OF MAKING AND METHODS OF USING

#944 ✅ Patent 12,133,859 granted on 2024-11-05
US20240325423A1
Human necessities

Topical compositions

#945
US20240325424A1
Human necessities

Pharmaceutical Compositions And Methods For Treating Neoplasia

#946
US20240325425A1
Human necessities

ALLELE-SELECTIVE COMPOUNDS AND METHODS FOR MODULATING HUNTINGTIN EXPRESSION

#947
US20240325426A1
Human necessities

POLYNUCLEOTIDE AND PHARMACEUTICAL COMPOSITION

#948
US20240325427A1
Human necessities

TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)

#949
US20240325428A1
Human necessities

NUCLEIC ACID, COMPOSITION AND CONJUGATE CONTAINING SAME, AND PREPARATION METHOD AND USE

#950
US20240325429A1
Human necessities

MINOR SPLICEOSOME TARGETING COMPOSITIONS AND THEIR USE IN CANCER TREATMENT

#951
US20240325430A1
Human necessities

MULTIPLE FOLATE FORMULATION AND USE THEREOF

#952
US20240325431A1
Human necessities

COMPOSITION FOR PURIFICATION OF BIOFLUIDS

#953
US20240325432A1
Human necessities

COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION

#954
US20240325433A1
Human necessities

MOLECULAR ASSOCIATION OF BILE ACID OR BILE SALT AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR LOCALLY REDUCING FAT

#955
US20240325434A1
Human necessities

USES OF GLYCOSAMINOGLYCAN CONJUGATES

#956
US20240325435A1
Human necessities

METHODS OF USING COMPOUND OF GLYCOSAMINOGLYCAN

#957
US20240325436A1
Human necessities

Safe Flavoring Composition to Improve Compliance in Colon Cleansing Compositions

#958
US20240325437A1
Human necessities

METHODS AND COMPOSITIONS FOR USE IN IMPROVING ADAPTIVE IMMUNITY IN THE ELDERLY POPULATION

#959
US20240325438A1
Human necessities

Pharmaceutical Composition and Method for Treating or Preventing Candidiasis

#960 ✅ Patent 12,102,651 granted on 2024-10-01
US20240325439A1
Human necessities

SOLVENT-BASED METHOD FOR MAKING NANOCOMPOSITE PHARMACEUTICAL MATERIAL

#961
US20240325440A1
Human necessities

Zinc Phosphate Complex

#962
US20240325441A1
Human necessities

MODIFIED IMMUNE CELL AND USE THEREOF

#963
US20240325442A1
Human necessities

CAR VECTOR EXPRESSING IMMUNE REGULATORY FACTOR AND APPLICATION THEREOF

#964
US20240325443A1
Human necessities

CD3-EXPRESSING NATURAL KILLER CELLS WITH ENHANCED FUNCTION FOR ADOPTIVE IMMUNOTHERAPY

#965
US20240325444A1
Human necessities

CHIMERIC ANTIGEN RECEPTOR TO TARGET TROP-2-POSITIVE CANCERS

#966
US20240325445A1
Human necessities

Chimeric Antigen Receptors with BCMA Specificity and Uses Thereof

#967
US20240325446A1
Human necessities

TREATMENT WITH TUMOR INFILTRATING LYMPHOCYTE THERAPIES IN COMBINATION WITH CTLA-4 AND PD-1 INHIBITORS

#968
US20240325447A1
Human necessities

GENERATION OF T CELL LINES WITH SPECIFICITY AGAINST ONE OR MORE NEOANTIGENS

#969
US20240325448A1
Human necessities

COLD ATMOPSHERIC PLASMA TREATED PAN-CANCER EPITOPE PEPTIDE WITHIN THE COLLAGEN TYPE VI A-3 (COL6A3) PROTEIN AS CANCER VACCINE

#970
US20240325449A1
Human necessities

METHODS OF TREATING GLIOBLASTOMAS

#971
US20240325450A1
Human necessities

NKT-CELL SUBSET FOR IN VIVO PERSISTENCE AND THERAPEUTIC ACTIVITY AND PROPAGATION OF SAME

#972
US20240325451A1
Human necessities

METHODS OF INDUCING ORGAN TRANSPLANTATION IMMUNE TOLERANCE AND ASSOCIATED COMPOSITIONS AND METHODS

#973
US20240325452A1
Human necessities

METHODS AND COMPOSITIONS FOR DREADD-ACTIVATABLE CELLS FOR NEURAL REPAIR

#974
US20240325453A1
Human necessities

ENGINEERED GLIAL CELLS FOR DESIGNER NEURAL REPAIR

#975
US20240325454A1
Human necessities

GENOMIC EDITING OF RBM20 MUTATIONS

#976
US20240325455A1
Human necessities

CARDIAC STEM CELLS FOR CARDIAC REPAIR

#977
US20240325456A1
Human necessities

MULTIPOTENT LUNG PROGENITOR CELLS FOR LUNG REGENERATION

#978
US20240325457A1
Human necessities

PLACENTAL TISSUE PARTICULATE COMPOSITIONS AND METHODS OF USE

#979
US20240325458A1
Human necessities

COMPOSITION FOR PRODUCING BILE ACIDS

#980
US20240325459A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING DISORDERS ASSOCIATED WITH BILE ACIDS

#981
US20240325460A1
Human necessities

MOLECULAR BACTERIOTHERAPY TO CONTROL SKIN ENZYMATIC ACTIVITY

#982
US20240325461A1
Human necessities

COMBINATION THERAPIES FOR THE TREATMENT OF DISEASES

#983
US20240325462A1
Human necessities

PREPARATIONS OF AMMONIA OXIDIZING MICROORGANISMS AND RELATED PRODUCTS

#984
US20240325463A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INTESTINAL PARACELLULAR PERMEABILITY

#985
US20240325464A1
Human necessities

SYNERGISTIC BACTERIAL COMPOSITIONS AND METHODS OF PRODUCTION AND USE THEREOF

#986
US20240325465A1
Human necessities

PROBIOTIC (BACILLUS SUBTILIS) SUPPLEMENTATION FOR IMPROVEMENT OF BODY COMPOSITION IN FEMALE ATHLETES

#987
US20240325466A1
Human necessities

MICROBIOME-BASED COMPOSITION FOR PREVENTING AND TREATING MULTIDRUG-RESISTANT BACTERIAL INFECTIONS

#988
US20240325467A1
Human necessities

NUCLEOTIDE PROBIOTIC CAPSULE FOR DELAYING AGING

#989
US20240325468A1
Human necessities

COMPOSITION FOR TREATMENT OF AUTOIMMUNE DISEASES COMPRISING LACTOBACILLUS SAKEI OR EXTRACELLULAR VESICLES DERIVED THEREFROM AS ACTIVE INGREDIENT

#990
US20240325469A1
Human necessities

COMPOSITION FOR PREVENTION OR TREATMENT OF COGNITIVE DYSFUNCTION AND INTESTINAL DYSFUNCTION, COMPRISING LACTOBACILLUS PARACASEI NK112, CUSCUTA AUSTRALIS EXTRACT, AND CUSCUTA JAPONICA EXTRACT

#991
US20240325470A1
Human necessities

PARENTERAL DELIVERY DEVICE AND METHODS OF USE

#992
US20240325471A1
Human necessities

COMPOSITIONS CONTAINING CURCUMIN HAVING IMPROVED BIOAVAILABILITY

#993
US20240325472A1
Human necessities

ONCOLYTIC ADENOVIRUSES ARMED WITH HETEROLOGOUS GENES

#994
US20240325473A1
Human necessities

Cancer Treatments

#995
US20240325474A1
Human necessities

BOTANICAL EXTRACTS TO INHIBIT VIRUS INFECTION

#996
US20240325475A1
Human necessities

PHYSIOLOGICALLY ACCEPTABLE YEAST COMPOSITIONS FOR USE IN THE TREATMENT OF A GASTRO-INTESTINAL DISORDER

#997
US20240325476A1
Human necessities

METHOD FOR ALLEVIATING DRY EYE DISEASE

#998
US20240325477A1
Human necessities

PROTEIN HYDROLYSATE OF MORINGA PEREGRINA SEED CAKE FOR ITS APPLICATION AS A MEDICAMENT, PROCESS FOR OBTAINING SAME AND PHARMACEUTICAL AND DERMATOLOGICAL COMPOSITIONS

#999 ✅ Patent 12,194,070 granted on 2025-01-14
US20240325478A1
Human necessities

Traditional chinese medicine compound for improving testicular dysfunction, preparation method and application thereof

#1000
US20240325479A1
Human necessities

Total extract of Fructus Cnidii and its application and map construction method

#1001
US20240325480A1
Human necessities

TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING URTICARIA, ECZEMA, AND ALLERGIC CONSTITUTION

#1002 ✅ Patent 12,246,052 granted on 2025-03-11
US20240325481A1
Human necessities

Antimicrobial hevamine A-related compositions and methods

#1003
US20240325482A1
Human necessities

NOVEL COMPOSITION COMPRISING NEPETA CATARIA-DERIVED EXOSOMES AS ACTIVE INGREDIENT

#1004
US20240325483A1
Human necessities

Compositions And Methods Of BDNF Activation

#1005
US20240325484A1
Human necessities

COMPOSITION COMPRISING HORSE CHESTNUT EXTRACT

#1006
US20240325485A1
Human necessities

COMPOSITION COMBINATION CONTAINING ENRICHED HILL SHADDOCK OIL

#1007
US20240325486A1
Human necessities

METHODS FOR TREATING SYMPTOMS OF DRY EYE DISEASE

#1008
US20240325487A1
Human necessities

COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT

#1009
US20240325488A1
Human necessities

REGENERATING FUNCTIONAL NEURONS FOR TREATMENT OF HEMORRHAGIC STROKE

#1010
US20240325489A1
Human necessities

CONNEXIN 43 FOR USE IN THE TREATMENT OF RETINOBLASTOMA PROTEIN POSITIVE TUMOURS

#1011
US20240325490A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ISCHEMIC CEREBROVASCULAR DISEASE

#1012
US20240325491A1
Human necessities

RECOMBINANT PROTEINS, COMPOSITIONS AND METHODS OF STABILIZATION THEREOF

#1013
US20240325492A1
Human necessities

PROTEIN FUNCTIONALIZED HYALURONIC ACID COATED CHITOSAN NANOPARTICLE AND METHOD OF PREPARATION

#1014
US20240325493A1
Human necessities

REGULATOR OF TUMOR CELL FUNCTIONS AND USES THEREOF

#1015
US20240325494A1
Human necessities

INTERLEUKIN-18 VARIANTS AND METHODS OF USE

#1016
US20240325495A1
Human necessities

FUSION PROTEINS FOR THE TREATMENT OF DISEASE

#1017
US20240325496A1
Human necessities

CXC CHEMOKINE AGONISTS AND ANTAGONISTS IN COVID-19 DISEASE AND DIAGNOSTIC ASSAYS

#1018
US20240325497A1
Human necessities

COMPOSITION FOR PREVENTING OR TREATING LIVER DISEASES, COMPRISING STC-1 OR DERIVATIVE THEREOF

#1019
US20240325498A1
Human necessities

METHODS OF USING AND COMPOSITIONS INCLUDING AN INCRETIN ANALOG

#1020
US20240325499A1
Human necessities

FGF21 COMPOUND / GLP-1R AGONIST COMBINATIONS WITH OPTIMIZED ACTIVITY RATIO

#1021
US20240325500A1
Human necessities

MANUFACTURE, FORMULATION AND DOSING OF APRAGLUTIDE

#1022
US20240325501A1
Human necessities

COMPOSITIONS AND METHODS TO SUPPRESS TUMOR GROWTH IN BONE, PREVENT CACHECTIC MUSCLE LOSS, AND PRESERVE SKELETAL INTEGRITY

#1023
US20240325502A1
Human necessities

PROTEIN NANOSPHERES TO TREAT RENAL FAILURE, DYSFUNCTION OR DAMAGE

#1024
US20240325503A1
Human necessities

WOUND HEALING AND TISSUE REPAIR COMPOSITION AND METHOD USING LOW MOLECULAR WEIGHT COLLAGEN AND BIOACTIVE GLASS

#1025
US20240325504A1
Human necessities

TREATMENT

#1026
US20240325505A1
Human necessities

Pharmaceutical Composition for Improving and Treating Leukotrichia and/or Alopecia and Preparation Method Thereof

#1027
US20240325506A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATMENT OF GAUCHER DISEASE

#1028
US20240325507A1
Human necessities

GLYCOSIDE HYDOLASES AND THEIR USE IN PREVENTING AND/OR TREATING A PATHOGENIC INFECTION IN AN ANIMAL

#1029
US20240325508A1
Human necessities

Microbial Lysozyme for use in the Treatment of Irritable Bowel Syndrome or Inflammatory Bowel Disease

#1030
US20240325509A1
Human necessities

METHODS AND COMPOSITIONS FOR T-CELL COCULTURE POTENCY ASSAYS AND USE WITH CELL THERAPY PRODUCTS

#1031
US20240325510A1
Human necessities

Novel anti-cancer vaccine composition and a method of vaccination using the same

#1032
US20240325511A1
Human necessities

Use of a Vaccine Targeting a Cryptic Tert Epitope, for Treating Cancer in a HLA-A*0201-Positive Patient Having a Non-Immunogenic Tumor Expressing Tert

#1033
US20240325512A1
Human necessities

VACCINE FOR PROTECTION AGAINST ETEC-INDUCED DIARRHEA COMPRISING DMLT

#1034
US20240325513A1
Human necessities

ESCHERICHIA COLI COMPOSITIONS AND METHODS THEREOF

#1035
US20240325514A1
Human necessities

A VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS OF VARIOUS SEROTYPES

#1036
US20240325515A1
Human necessities

Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof

#1037
US20240325516A1
Human necessities

PURIFIED CAPSULAR POLYSACCHARIDES OF STREPTOCOCCUS PNEUMONIAE

#1038
US20240325517A1
Human necessities

COMPOSITIONS AND METHODS TARGETING FILAMENTOUS BACTERIOPHAGE

#1039
US20240325518A1
Human necessities

METHOD FOR INACTIVATING ZIKA VIRUS AND FOR DETERMINING THE COMPLETENESS OF INACTIVATION

#1040
US20240325519A1
Human necessities

VACCINE MOLECULES

#1041 ✅ Patent 12,324,833 granted on 2025-06-10
US20240325520A1
Human necessities

Recombinant Severe Acute Respiratory Syndrome Coronavirus 2 Rbd Trimer Protein Vaccine Capable Of Generating Broad-Spectrum Cross Neutralization Activity, and Preparation Method and Use Thereof

#1042
US20240325521A1
Human necessities

IONIZABLE LIPID COMPOUND FOR NUCLEIC ACID DELIVERY AND LNP COMPOSITION THEREOF

#1043
US20240325522A1
Human necessities

RNA ADSORBED ONTO LIPID NANO-EMULSION PARTICLES AND ITS FORMULATIONS

#1044
US20240325523A1
Human necessities

CORONAVIRUS AND INFLUENZA COMPOSITIONS AND METHODS FOR USING THEM

#1045
US20240325524A1
Human necessities

COMPOSITIONS AND METHODS FOR INDUCING IMMUNE TOLERANCE

#1046
US20240325525A1
Human necessities

Lipid Nanoparticles for Delivery of Nucleic Acids and Methods of Use Thereof

#1047
US20240325526A1
Human necessities

IMMUNE-STIMULATORY COMPOSITIONS AND USE THEREOF

#1048
US20240325527A1
Human necessities

METHODS FOR PROMOTING TISSUE REGENERATION

#1049
US20240325528A1
Human necessities

SUBCUTANEOUS UNIT DOSAGE FORMS

#1050
US20240325529A1
Human necessities

MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCER

#1051
US20240325530A1
Human necessities

COMBINATION THERAPIES

#1052
US20240325531A1
Human necessities

CAR T/NK-CELLS FOR USE IN THE TREATMENT OF INVASIVE FUNGAL INFECTIONS

#1053
US20240325532A1
Human necessities

COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND CHIMERIC ANTIGEN RECEPTOR (CAR)-IMMUNE CELLS

#1054
US20240325533A1
Human necessities

MODIFIED IMMUNE CELLS AND METHODS OF USING THE SAME

#1055
US20240325534A1
Human necessities

CHIMERIC ANTIGEN RECEPTOR (CAR)-T SIGNALING OPTIMIZATION FOR TUNING ANTIGEN ACTIVATION THRESHOLD

#1056
US20240325535A1
Human necessities

COMPOSITIONS AND METHODS COMPRISING CAR T CELLS COMPRISING PRDM1 AND/OR NR4A3 KNOCKOUT

#1057
US20240325536A1
Human necessities

TRANSPLANTED CELL PROTECTION VIA MODIFIED Fc RECEPTORS

#1058
US20240325537A1
Human necessities

CELLULAR THERAPIES FOR CANCER BY INHIBITION OF MONOCARBOXYLATE TRANSPORTER 11

#1059
US20240325538A1
Human necessities

TUMOR INFILTRATION LYMPHOCYTE CULTURE MEDIUM AND APPLICATION THEREOF

#1060
US20240325539A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING EPSTEIN BARR VIRUS-ASSOCIATED CANCER

#1061
US20240325540A1
Human necessities

METHOD OF ENHANCING HUMAN IMMUNITY THROUGH SOLID WATER PARTICLES

#1062
US20240325541A1
Human necessities

PARTICULATE SUBSTANCES COMPRISING CERAMIC PARTICLES FOR DELIVERY OF BIOMOLECULES

#1063
US20240325542A1
Human necessities

USE OF A PHOSPHOLIPID AS A CRYSTALLIZATION INHIBITOR

#1064
US20240325543A1
Human necessities

THERAPEUTIC SUSPENSION COMPOSITIONS

#1065
US20240325544A1
Human necessities

CATIONIC LIPID FOR COVALENT MODIFICATION OF PEPTIDES

#1066
US20240325545A1
Human necessities

Phospholipid-Flavagline Conjugates and Methods of Using the Same for Targeted Cancer Therapy

#1067
US20240325546A1
Human necessities

TOPICAL DELIVERY OF THERAPEUTIC OLIGONUCLEOTIDES

#1068
US20240325547A1
Human necessities

MODULATORS OF BCL6 PROTEOLYSIS AND ASSOCIATED METHODS OF USE

#1069
US20240325548A1
Human necessities

DYNAMIC BIOACTIVE SCAFFOLDS AND THERAPEUTIC USES THEREOF AFTER CNS INJURY

#1070
US20240325549A1
Human necessities

GLP-1/GIP DUAL AGONIST, PREPARATION METHOD AND USE THEREOF

#1071
US20240325550A1
Human necessities

Therapeutic Compounds for Inhibiting and Reducing the Expression of Cell Surface Proteins

#1072
US20240325551A1
Human necessities

METASTATIC BRAIN TUMOR TARGETING PEPTIDES

#1073
US20240325552A1
Human necessities

BLOCK COPOLYMERS

#1074
US20240325553A1
Human necessities

CYTOSTATIC CONJUGATES WITH INTEGRIN LIGANDS

#1075
US20240325554A1
Human necessities

METHODS FOR TREATING CANCER

#1076 ✅ Patent 12,194,106 granted on 2025-01-14
US20240325555A1
Human necessities

Antibodies targeting LIV-1 and uses thereof

#1077
US20240325556A1
Human necessities

Methods of Using Antibody-Drug-Conjugates

#1078
US20240325557A1
Human necessities

TREATMENT OF CANCER

#1079
US20240325558A1
Human necessities

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING MYOTONIC DYSTROPHY

#1080
US20240325559A1
Human necessities

STABLE ANTI-CD79B IMMUNOCONJUGATE FORMULATIONS

#1081
US20240325560A1
Human necessities

COMPOUND FOR THE SEQUESTRATION OF UNDESIRABLE ANTIBODIES IN A PATIENT

#1082
US20240325561A1
Human necessities

PEGYLATED DRUG-LINKERS FOR IMPROVED LIGAND-DRUG CONJUGATE PHARMACOKINETICS

#1083
US20240325562A1
Human necessities

INTERNALIZING BINDING MOLECULES

#1084
US20240325563A1
Human necessities

TARGETED DELIVERY OF IMMUNOREGULATORY DRUGS

#1085
US20240325564A1
Human necessities

PHARMACEUTICAL COMPOSITION CONTAINING ANTI-TROP2 ANTIBODY DRUG CONJUGATE AND ITS APPLICATION

#1086
US20240325565A1
Human necessities

COMBINATION TREATMENT FOR SOLID TUMORS INCLUDING A STING AGONIST AND A CCR2 ANTAGONIST

#1087
US20240325566A1
Human necessities

NANOPARTICLES FOR USE IN PHOTODYNAMIC THERAPIES AND METHODS OF MAKING, EVALUATING AND USING THE SAME

#1088
US20240325567A1
Human necessities

CELL THERAPY

#1089
US20240325568A1
Human necessities

ENGINEERED TARGETING COMPOSITIONS FOR ENDOTHELIAL CELLS OF THE CENTRAL NERVOUS SYSTEM VASCULATURE AND METHODS OF USE THEREOF

#1090
US20240325569A1
Human necessities

Gene therapy DNA vector based on gene therapy DNA vector VTvaf17 carrying the therapeutic gene selected from the group of BDNF, VEGFA, BFGF, NGF, GDNF, NT3, CNTF, and IGF1 genes for increasing the expression level of these therapeutic genes, method of its production and use, Escherichia coli strain SCS110-AF/VTvaf17-BDNF, or Escherichia coli strain SCS110-AF/VTvaf17-VEGFA, or Escherichia coli strain SCS110-AF/VTvaf17-BFGF, or Escherichia coli strain SCS110-AF/VTvaf17-NGF, or Escherichia coli str

#1091
US20240325570A1
Human necessities

TREATING DISEASES AND IMPROVING NUCLEIC ACID DELIVERY

#1092
US20240325571A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISEASE

#1093
US20240325572A1
Human necessities

N-HETEROCYCLYL SUBSTITUTED 2-CYANO-3-(NAPHTHALEN-2-YL)ACRYLAMIDE DERIVATIVES AS FLUOROPHORS FOR DETECTION OF AMYLOID AND AMYLOID-LIKE PROTEINS FOR DIAGNOSIS OF NEURODEGENERATIVE DISORDERS

#1094
US20240325573A1
Human necessities

X-RAY DEVELOPABLE MOLECULE, EMBOLISM MICROSPHERE AND PREPARATION METHODS THEREFOR

#1095
US20240325574A1
Human necessities

EXTRADOMAIN B FIBRONECTIN TARGETING PEPTIDES AND DERIVATIVES FOR CANCER IMAGING AND THERAPY

#1096
US20240325575A1
Human necessities

LABELING OF ANTIBODIES

#1097
US20240325576A1
Human necessities

STERILIZER SYSTEM FOR GROOMING IMPLEMENTS

#1098
US20240325577A1
Human necessities

SANITATION DEVICE FOR STETHOSCOPE

#1099 ✅ Patent 12,311,068 granted on 2025-05-27
US20240325578A1
Human necessities

UV disinfection box system

#1100 ✅ Patent 12,343,441 granted on 2025-07-01
US20240325579A1
Human necessities

STERILIZATION UNIT AND STERILIZATION APPARATUS INCLUDING THE SAME

#1101
US20240325580A1
Human necessities

STERILIZATION MODULE AND ELECTRONIC DEVICE COMPRISING SAME

#1102
US20240325581A1
Human necessities

DEVICE, SYSTEMS, AND METHODS FOR ENHANCED IONIZED HYDROGEN PEROXIDE DECONTAMINATION

#1103
US20240325582A1
Human necessities

SYSTEM AND METHOD FOR STERILIZATION OF OBJECTS

#1104
US20240325583A1
Human necessities

RESPIRATORY DEVICE

#1105 ✅ Patent 12,280,170 granted on 2025-04-22
US20240325584A1
Human necessities

Disinfection systems and methods

#1106
US20240325585A1
Human necessities

SCENT COLLECTION SYSTEM AND METHOD

#1107
US20240325586A1
Human necessities

METHOD AND SYSTEM FOR SANITIZING SURFACES AND IN A CONFINED ENVIRONMENT

#1108
US20240325587A1
Human necessities

METHOD AND SYSTEM FOR SANITIZING SURFACES AND IN A CONFINED ENVIRONMENT

#1109
US20240325588A1
Human necessities

FILTER FOR AIR PURIFICATION AND MANUFACTURING METHOD THEREOF

#1110
US20240325589A1
Human necessities

Loudspeaker with Negative Air Ions Generator

#1111
US20240325590A1
Human necessities

DISINFECTION SYSTEM OF CONTACT LENS

#1112
US20240325591A1
Human necessities

FILMS WITH MALODOR CONTROL

#1113
US20240325592A1
Human necessities

LIQUID EMBOLIC MATERIALS

#1114
US20240325593A1
Human necessities

OCCLUSIVE IMPLANT COMPOSITIONS

#1115
US20240325594A1
Human necessities

LIQUID EMBOLIC MATERIALS

#1116
US20240325595A1
Human necessities

Alginate Based Particles as a Temporary Embolic Agent

#1117
US20240325596A1
Human necessities

MINERAL-COATED SUBSTRATES FOR STABILIZATION OF RNA-BASED THERAPEUTIC COMPOSITIONS

#1118
US20240325597A1
Human necessities

GRAFTED OPHTHALMIC DEVICES CONTAINING DEACTIVATED REGIONS AND PROCESSES FOR THEIR PREPARATION AND USE

#1119
US20240325598A1
Human necessities

COMPOSITIONS HAVING CHAIR-SIDE HANDLING PROPERTIES FOR DENTAL AND SOFT TISSUE APPLICATIONS

#1120
US20240325599A1
Human necessities

LARGE APERTURE-BASED TISSUE ENGINEERING SCAFFOLD AND USE THEREOF

#1121
US20240325600A1
Human necessities

POROUS BIOLOGICAL AMNIOTIC MEMBRANE PUNCTURE DEVICE AND PREPARATION METHOD

#1122
US20240325601A1
Human necessities

BONE GROWTH COMPOSITIONS AND ASSOCIATED TECHNIQUES

#1123
US20240325602A1
Human necessities

DEMINERALIZED BONE FIBER COMPOSITION FOR ROTATOR CUFF AND ACL REPAIR

#1124
US20240325603A1
Human necessities

PANCREATIC CELL RECEIVING MATRIX AND IMPROVED ARTIFICIAL PANCREAS DEVICE

#1125
US20240325604A1
Human necessities

THIN FILM INTERPOSITION OF BASEMENT MEMBRANE SCAFFOLDS

#1126
US20240325605A1
Human necessities

Tissue Scaffold with Patterned Microstructure

#1127
US20240325606A1
Human necessities

COLLAGEN-BASED HYDROGELS, CORNEAL IMPLANTS, FILLER GLUE AND USES THEREOF

#1128
US20240325607A1
Human necessities

IN SITU EXPANSION OF ENGINEERED DEVICES FOR REGENERATION

#1129
US20240325608A1
Human necessities

DELIVERY SYSTEM AND METHOD FOR USING SAME

#1130
US20240325609A1
Human necessities

POLYPEPTIDE MONOLITHS

#1131
US20240325610A1
Human necessities

DRUG COATING, DRUG-COATED BALLOON AND PREPARATION METHOD THEREOF

#1132
US20240325611A1
Human necessities

NEEDLELESS ACCESS CONNECTOR WITH ANTIMICROBIAL RESISTANT VALVE

#1133
US20240325612A1
Human necessities

ACOUSTIC MATCHING MATERIALS AND METHODS FOR PREPARING THEREOF, AND ULTRASONIC PROBES

#1134
US20240325613A1
Human necessities

BREAST PUMP

#1135
US20240325614A1
Human necessities

SYSTEM AND METHOD FOR CARDIOPULMONARY BYPASS USING HYPOBARIC OXYGENATION

#1136
US20240325615A1
Human necessities

SYSTEM FEATURING OPTICAL AND ELECTRICAL SENSORS FOR CHARACTERIZING EFFLUENT FROM A PERITONEAL DIALYSIS PATIENT

#1137
US20240325616A1
Human necessities

Systems and Methods For Controlling The Risk Of Citrate Reactions During Apheresis

#1138
US20240325617A1
Human necessities

SELF-SEALING CANNULA

#1139
US20240325618A1
Human necessities

BODILY FLUID DRAINAGE ASSEMBLY

#1140
US20240325619A1
Human necessities

DRESSINGS AND METHODS FOR TREATING A TISSUE SITE ON A PATIENT

#1141
US20240325620A1
Human necessities

System and Related Methods for Fat Harvesting

#1142
US20240325621A1
Human necessities

WOUND THERAPY SYSTEM WITH CONDUIT BLOCKAGE DETECTION

#1143
US20240325622A1
Human necessities

REMOTE MONITORING OF FLUID PRESSURE IN BIOLOGICAL TISSUE

#1144
US20240325623A1
Human necessities

DOUBLE LAYER TUBING FOR IV INFUSION SETS

#1145
US20240325624A1
Human necessities

TELESCOPIC TUBING EXTENSION SET

#1146
US20240325625A1
Human necessities

SYSTEM, METHOD, AND APPARATUS FOR ELECTRONIC PATIENT CARE

#1147
US20240325626A1
Human necessities

Attachable IV Manifold Device

#1148
US20240325627A1
Human necessities

INTRAVENOUS FLUID LINE CLIP

#1149 ✅ Patent 12,102,789 granted on 2024-10-01
US20240325628A1
Human necessities

IMPROVED RADIOPHARMACEUTICAL DELIVERY SYSTEM AND USE THEREOF FOR PATIENT INFUSION

#1150
US20240325629A1
Human necessities

CASSETTE WITH FREE FLOW PREVENTION FOR INFUSION PUMP

#1151
US20240325630A1
Human necessities

APPARATUS FOR INFUSING MEDICAL LIQUID

#1152
US20240325631A1
Human necessities

CANNULA ASSEMBLY FOR A WEARABLE DRUG DELIVERY DEVICE

#1153
US20240325632A1
Human necessities

PLATE WITH INTEGRAL FLUID PATH CHANNELS

#1154
US20240325633A1
Human necessities

INTRAVASCULAR ARTIFICIAL PANCREAS

#1155
US20240325634A1
Human necessities

WEARABLE INFUSION DEVICE

#1156
US20240325635A1
Human necessities

SYSTEMS FOR DELIVERING FLUID TO A USER TRANSCUTANEOUSLY

#1157
US20240325636A1
Human necessities

DUAL NEEDLE DELIVERY SYSTEM THAT CONNECTS AND DEPLOYS NEEDLES OF A MEDICATION DELIVERY DEVICE

#1158
US20240325637A1
Human necessities

DEVICES FOR USE IN DRUG DELIVERY SYSTEMS

#1159
US20240325638A1
Human necessities

INFUSION SET FOR EFFORTLESS FLOW ADJUSTMENT

#1160
US20240325639A1
Human necessities

BLOOD GLUCOSE ESTIMATION BASED ON RATE OF CHANGE INFORMATION

#1161
US20240325640A1
Human necessities

METHODS TO INCORPORATE SUBJECTIVE USER GLUCOSE CONCENTRATION FEEDBACK IN AUTOMATED INSULIN DELIVERY SYSTEMS

#1162
US20240325641A1
Human necessities

A delivery member guard locking member and a sub-assembly of a medicament delivery device

#1163
US20240325642A1
Human necessities

A subassembly of a medicament delivery device

#1164 ✅ Patent 12,233,244 granted on 2025-02-25
US20240325643A1
Human necessities

Autoinjector

#1165
US20240325644A1
Human necessities

DRIVING PISTON SET OF AN INJECTOR AND CONVERSION MECHANISM HAVING THE SAME

#1166
US20240325645A1
Human necessities

DRUG DELIVERY DEVICE HAVING DAMPING MECHANISM

#1167
US20240325646A1
Human necessities

INJECTOR NEEDLE CAP AND/OR LINER REMOVER

#1168
US20240325647A1
Human necessities

Components and sub-assemblies for medicament delivery devices

#1169
US20240325648A1
Human necessities

MEASUREMENT SYSTEM, MEASUREMENT METHOD, INJECTOR, AND METHOD FOR INJECTING BIOMOLECULE-CONTAINING SOLUTION INTO TO-BE-INJECTED CELL USING SAME

#1170
US20240325649A1
Human necessities

Syringe with Flat Indicia Display Surface

#1171
US20240325650A1
Human necessities

MEDICAL SYRINGE AND METHOD FOR REDUCING MEDICATION WASTE

#1172
US20240325651A1
Human necessities

AUTOINJECTOR WITH SHOCK REDUCING ELEMENTS

#1173
US20240325652A1
Human necessities

Components and subassemblies for medicament delivery devices

#1174
US20240325653A1
Human necessities

DUAL PIEZOELECTRIC STACK PLUNGER SUB-ASSEMBLY

#1175
US20240325654A1
Human necessities

Syringe Pump Vibration Module to Reduce Stopper Friction

#1176
US20240325655A1
Human necessities

DRUG DELIVERY DEVICE

#1177
US20240325656A1
Human necessities

EXOSTRUCTURE TO ASSIST IN ACCURATE SYRINGE INJECTION

#1178
US20240325657A1
Human necessities

Needle Guard Assembly for Fluid Removal From a Glass Ampoule

#1179
US20240325658A1
Human necessities

Safety System for a Medical Injection Device

#1180
US20240325659A1
Human necessities

ADMINISTRATION OF NAKED NUCLEIC ACID MOLECULE

#1181
US20240325660A1
Human necessities

Nasal Medication Or Drug Delivery Devices and Methods

#1182
US20240325661A1
Human necessities

FLOW REGULATING INHALER DEVICE

#1183 ✅ Patent 12,337,105 granted on 2025-06-24
US20240325662A1
Human necessities

AEROSOLIZATION USING TWO AEROSOL GENERATORS

#1184 ✅ Patent 12,337,106 granted on 2025-06-24
US20240325663A1
Human necessities

SYSTEM AND METHOD FOR A VAPORIZER

#1185
US20240325664A1
Human necessities

ELECTRONIC VAPING DEVICE WITH TUBULAR HEATING ELEMENT

#1186
US20240325665A1
Human necessities

SYSTEMS AND METHODS FOR ANESTHESIA MACHINES WITH VENTILATOR DRIVE GAS INSPIRATORY FLOW

#1187
US20240325666A1
Human necessities

PATIENT INTERFACE WITH INTEGRATED JET PUMP

#1188
US20240325667A1
Human necessities

ENDOTRACHEAL TUBES WITH BAFFLES

#1189
US20240325668A1
Human necessities

GUIDANCE SYSTEM

#1190
US20240325669A1
Human necessities

A PATIENT INTERFACE AND A POSITIONING AND STABILISING STRUCTURE FOR A PATIENT INTERFACE

#1191 ✅ Patent 12,109,362 granted on 2024-10-08
US20240325670A1
Human necessities

Nasal breathing and ventilation device

#1192
US20240325671A1
Human necessities

AIR QUALITY ANALYSIS DEVICE

#1193
US20240325672A1
Human necessities

Systems and Methods for Generating Nitric Oxide

#1194
US20240325673A1
Human necessities

METHOD TO DETERMINE AN INITIAL WATER VOLUME IN A HUMIDIFIER AND PREDICTING THE WATER VOLUME OVER TIME

#1195
US20240325674A1
Human necessities

HUMIDIFIED GASES DELIVERY APPARATUS AND METHODS FOR CONTROLLING SAME

#1196
US20240325675A1
Human necessities

VALVE

#1197
US20240325676A1
Human necessities

METHODS AND SYSTEMS FOR GATHERING AND ANALYZING HUMAN BIOLOGICAL SIGNALS

#1198
US20240325677A1
Human necessities

SLEEP POD

#1199
US20240325678A1
Human necessities

THERAPEUTIC SOUND THROUGH BONE CONDUCTION

#1200
US20240325679A1
Human necessities

LOW-BLUE LIGHT SOURCE